Built for a market that demands continuity
CuraMed Healthcare was established to give principals a dependable route into Syria at a time when few could offer one.
Why CuraMed exists
Supplying medicines in Syria means working through conditions that change faster than most markets. Import authorisations, currency, transport and storage all carry more risk here than they would elsewhere, and a principal who cannot see how those risks are being handled is unlikely to commit a product to the market.
CuraMed Healthcare was set up to take that work on and to make it visible. We hold the registrations, run the warehouse and the cold chain, manage the import and delivery, and report back to the companies we represent in the detail their own quality teams need.
That posture shapes how we operate. We would rather carry fewer products and hold the standard than carry more and explain afterwards why something slipped.
CuraMed Healthcare is part of the Fattal Group, a family business with a long history of pharmaceutical and consumer healthcare distribution across the Levant. That association gives us access to established distribution practice, quality systems and supplier relationships that would take years to build alone.
Part of the Fattal Group
What we are working towards
- Mission
- To make quality medicines reliably available in Syria by giving the companies that make them a partner who handles registration, supply and compliance to the standard their own markets expect.
- Vision
- A Syrian market where availability does not depend on improvisation, and where a principal can plan supply here with the same confidence they plan it anywhere else.
How we work
Integrity
We tell principals what has happened, including when it is inconvenient. A problem reported early is a problem that can still be solved.
Compliance
Regulatory and quality requirements are the shape of the work, not an obstacle to it. Where a standard applies, we operate to it and we keep the records.
Patient focus
Every decision about storage, transport and supply ends with a patient taking a medicine. That is the test we apply.
Partnership
We act as an extension of the companies we represent, not as an intermediary with its own agenda.
Continuity
Supply that holds through difficult conditions is worth more than supply that is fast when conditions are easy.
Considering representation in Syria?
We are glad to talk through what the market requires before anything is committed.